HSBC raises Regeneron Pharma price target to $920 from $800
HSBC maintained Regeneron Pharma at Buy and raised its price target to $920.00 per share from $800.00, according to TradingView News ratings actions
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.